As of early September 2026, the CDC has confirmed 3,134 measles cases nationwide this year, driven by sustained local transmission across 47 jurisdictions amid 38 ongoing or new outbreaks, with 95% of cases linked to these clusters. Low MMR vaccination coverage—94% of cases occurring in unvaccinated or unknown-status individuals—remains the core driver, enabling rapid spread in under-immunized communities, particularly in states like Pennsylvania, South Carolina, and Utah where recent surges have added dozens of cases weekly. Measles’ high contagiousness (airborne transmission with a basic reproduction number of 12–18) and the 8% hospitalization rate underscore ongoing risk through September 30. Weekly CDC surveillance updates and state health department reports will provide the key data releases that could shift market-implied odds on total case thresholds.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertMasernfälle in den USA bis zum 30. September?
Masernfälle in den USA bis zum 30. September?
NEU
30. Sep. 2026
3800+
8%
4000+
33%
3200+
99%
3300+
98%
3400+
98%
3500+
93%
$6,865 Vol.
3800+
$134 Vol.
8%
4000+
$55 Vol.
33%
3200+
$1,957 Vol.
99%
3300+
$172 Vol.
98%
3400+
$286 Vol.
98%
3500+
$633 Vol.
93%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the CDC has confirmed 3,134 measles cases nationwide this year, driven by sustained local transmission across 47 jurisdictions amid 38 ongoing or new outbreaks, with 95% of cases linked to these clusters. Low MMR vaccination coverage—94% of cases occurring in unvaccinated or unknown-status individuals—remains the core driver, enabling rapid spread in under-immunized communities, particularly in states like Pennsylvania, South Carolina, and Utah where recent surges have added dozens of cases weekly. Measles’ high contagiousness (airborne transmission with a basic reproduction number of 12–18) and the 8% hospitalization rate underscore ongoing risk through September 30. Weekly CDC surveillance updates and state health department reports will provide the key data releases that could shift market-implied odds on total case thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Markt eröffnet: Aug 26, 2026, 5:27 AM ET
Volumen
$6,865Enddatum
1. Okt. 2026Markt eröffnet
Aug 26, 2026, 5:27 AM ETAbwickler
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the CDC has confirmed 3,134 measles cases nationwide this year, driven by sustained local transmission across 47 jurisdictions amid 38 ongoing or new outbreaks, with 95% of cases linked to these clusters. Low MMR vaccination coverage—94% of cases occurring in unvaccinated or unknown-status individuals—remains the core driver, enabling rapid spread in under-immunized communities, particularly in states like Pennsylvania, South Carolina, and Utah where recent surges have added dozens of cases weekly. Measles’ high contagiousness (airborne transmission with a basic reproduction number of 12–18) and the 8% hospitalization rate underscore ongoing risk through September 30. Weekly CDC surveillance updates and state health department reports will provide the key data releases that could shift market-implied odds on total case thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$6,865Enddatum
1. Okt. 2026Markt eröffnet
Aug 26, 2026, 5:27 AM ETAbwickler
0x65070BE91...As of early September 2026, the CDC has confirmed 3,134 measles cases nationwide this year, driven by sustained local transmission across 47 jurisdictions amid 38 ongoing or new outbreaks, with 95% of cases linked to these clusters. Low MMR vaccination coverage—94% of cases occurring in unvaccinated or unknown-status individuals—remains the core driver, enabling rapid spread in under-immunized communities, particularly in states like Pennsylvania, South Carolina, and Utah where recent surges have added dozens of cases weekly. Measles’ high contagiousness (airborne transmission with a basic reproduction number of 12–18) and the 8% hospitalization rate underscore ongoing risk through September 30. Weekly CDC surveillance updates and state health department reports will provide the key data releases that could shift market-implied odds on total case thresholds.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen